Johnson & Johnson History, CEO, Future

Johnson & Johnson is an American healthcare and pharmaceutical company. Founded in 1886 in New Jersey, it is now one of the world's largest manufacturers of medical devices, medicines, and healthcare. We produce a variety of health-related products, and we have also expanded our scope to include pharmaceuticals, medical devices, and consumer products. Some of Johnson & Johnson's products include medical devices such as in vitro diagnostics, blood pressure gauges, artificial hearts and joints, as well as a range of products such as baby products, adult pesticides, skin infections treatments and natural medicines. Johnson & Johnson is one of the international pharmaceutical and biotechnology research and development companies. We are investing heavily in the development of new drugs and treatments, and we are focusing on the treatment of diseases such as cancer, heart disease, encephalopathy, asthma, and diabetes. Johnson & Johnson conducts various donation and social contribution activities, and has gained a lot of popularity and trust around the world.

1. Johnson and Johnson History

In 1886, brothers Robert Wood Johnson and Edward Medley Johnson founded Johnson & Johnson in New Jersey. Johnson & Johnson focused on manufacturing initial wound disinfectants, and has since continued to expand its health-related products. In the mid-20th century, Johnson & Johnson launched a range of medicines, including allergies, atopic dermatitis, and painkillers, along with medical devices. 1959 was the turning point of Johnson & Johnson to acquire Husskiss. In the 1970s, the acquisition of the plastic product manufacturer Milliken further strengthened its position in medical device manufacturing. Since then, it has also entered advanced medical devices such as artificial hearts and artificial joints. In the 21st century, as we grew around the world, we acquired and merged with many companies in medical devices, medicine, and biotechnology. Along with this growth, Johnson & Johnson is recognized worldwide as a medical device and pharmaceutical company.

2. Johnson & Johnson CEO

The current CEO of Johnson & Johnson is Alex Gorsky. Alex Gorsky was appointed CEO of Johnson & Johnson in 2012, and has served in that role to date. Alex Gorsky was born in the U.S. state of New Jersey and joined Johnson & Johnson after completing his doctorate. I joined the company in 1988 and worked in various departments. In 2001, he was appointed CEO of the Manhattan Medical Devices Division and held executive positions in various fields, including medical devices and pharmaceuticals. Alex Gorsky is working with the company's vision of "making a healthier world." He aims to develop innovative products and services, grow in a sustainable way, and fulfill social responsibilities so that the company can become an internationally respected company.

3. The Future of Johnson & Johnson

Johnson & Johnson is a globally recognized company that provides health-related products and health-related services. We focus on developing innovative products and services in a variety of fields and improving customer health and satisfaction. Future Johnson & Johnson is expected to develop more innovative products and services, grow in a more sustainable way, and fulfill its social responsibilities. In particular, we are also interested in the field of providing personalized treatment and health care services using artificial intelligence and data analysis technology. Johnson & Johnson strives to continue to grow without being culled. We develop environmentally friendly products and production processes, actively promote carbon emissions reduction and renewable energy use, and operate our business in a socially responsible manner. Johnson & Johnson is expected to grow in a more innovative and sustainable way in the future.

※Johnson & Johnson Stock Price Analysis

Looking at Johnson & Johnson's past stock trends, the stock has been on a steady rise from 2012 to May 2022. However, stock prices have not always risen or been stable, and in 2018, they have also temporarily declined. These stock price fluctuations caused stock prices to rise when positive news such as new product launches, performance, mergers and acquisitions came out, and on the contrary, stock prices to fall when negative news such as recession or industry competitiveness came out. In other words, stock price analysis should be carried out in comprehensive consideration of internal and external factors, rather than simply looking at past trends, and professional analysis is required.

j&j, Johnson & Johnson